featured
Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rivaroxaban Plus Aspirin in Obese and Overweight Patients With Vascular Disease in the COMPASS Trial
J Am Coll Cardiol 2021 Feb 09;77(5)511-525, TJ Guzik, C Ramasundarahettige, N Pogosova, P Lopez-Jaramillo, L Dyal, SD Berkowitz, E Muehlhofer, DL Bhatt, KAA Fox, S Yusuf, JW EikelboomFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.